▶ 調査レポート

鉄キレート剤の世界市場レポート2020

• 英文タイトル:Global Iron Chelation Drug Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。鉄キレート剤の世界市場レポート2020 / Global Iron Chelation Drug Sales Market Report 2020 / 20QY06-07487資料のイメージです。• レポートコード:20QY06-07487
• 出版社/出版日:QYResearch / 2020年6月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、鉄キレート剤のグローバル市場について種類別(デフェロキサミン、デフェリプロン、デフェラシロックス)、用途別(輸血による鉄過剰、NTDTによる鉄過剰)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・鉄キレート剤市場の概要
・世界の主要地域別鉄キレート剤市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の鉄キレート剤市場規模2015-2026:種類別(デフェロキサミン、デフェリプロン、デフェラシロックス)
・世界の鉄キレート剤市場規模2015-2026:用途別(輸血による鉄過剰、NTDTによる鉄過剰)
・鉄キレート剤の北米市場規模2015-2020
・鉄キレート剤のヨーロッパ市場規模2015-2020
・鉄キレート剤の中国市場規模2015-2020
・鉄キレート剤の日本市場規模2015-2020
・鉄キレート剤の東南アジア市場規模2015-2020
・鉄キレート剤のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Apotex Inc. (Canada)、Cipla (India)、Novartis (Switzerland)、Sun Pharma (India)、Natco Pharma (India))
・鉄キレート剤の製造コスト分析
・販売チャネル、流通業者、顧客
・鉄キレート剤の市場動向・機会・課題
・調査の結論

This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
North America is the largest consumption region of Iron Chelation Drug, with a consumption value market share nearly 31.03% in 2016. Europe is the second largest consumption region of Iron Chelation Drug, enjoying consumption value market share nearly 25.30% in 2016. Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Iron Chelation Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Iron Chelation Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Iron Chelation Drug industry.
Based on our recent survey, we have several different scenarios about the Iron Chelation Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 4547.6 million in 2019. The market size of Iron Chelation Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Iron Chelation Drug Scope and Market Size
The global Iron Chelation Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Iron Chelation Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Iron Chelation Drug market is segmented into
Deferoxamine
Deferiprone
Deferasirox

Segment by Application, the Iron Chelation Drug market is segmented into
Transfusional Iron Overload
NTDT Caused Iron Overload

The Iron Chelation Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Iron Chelation Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Iron Chelation Drug Market Share Analysis
Iron Chelation Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Iron Chelation Drug business, the date to enter into the Iron Chelation Drug market, Iron Chelation Drug product introduction, recent developments, etc.

The major vendors covered:
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)

レポート目次

1 Iron Chelation Drug Market Overview
1.1 Iron Chelation Drug Product Scope
1.2 Iron Chelation Drug Segment by Type
1.2.1 Global Iron Chelation Drug Sales by Type (2020-2026)
1.2.2 Deferoxamine
1.2.3 Deferiprone
1.2.4 Deferasirox
1.3 Iron Chelation Drug Segment by Application
1.3.1 Global Iron Chelation Drug Sales Comparison by Application (2020-2026)
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Iron Chelation Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Iron Chelation Drug Sales Growth Rate (2015-2026)
1.4.2 Global Iron Chelation Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Iron Chelation Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Iron Chelation Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Iron Chelation Drug Industry
1.5.1.1 Iron Chelation Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Iron Chelation Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Iron Chelation Drug Players to Combat Covid-19 Impact

2 Iron Chelation Drug Estimate and Forecast by Region
2.1 Global Iron Chelation Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Iron Chelation Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Iron Chelation Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Iron Chelation Drug Revenue Market Share by Region (2015-2020)
2.3 Global Iron Chelation Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Iron Chelation Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Iron Chelation Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Iron Chelation Drug Estimates and Projections (2015-2026)
2.4.2 Europe Iron Chelation Drug Estimates and Projections (2015-2026)
2.4.3 China Iron Chelation Drug Estimates and Projections (2015-2026)
2.4.4 Japan Iron Chelation Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Iron Chelation Drug Estimates and Projections (2015-2026)
2.4.6 India Iron Chelation Drug Estimates and Projections (2015-2026)
3 Global Iron Chelation Drug Competition Landscape by Players
3.1 Global Top Iron Chelation Drug Players by Sales (2015-2020)
3.2 Global Top Iron Chelation Drug Players by Revenue (2015-2020)
3.3 Global Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Chelation Drug as of 2019)
3.4 Global Iron Chelation Drug Average Price by Company (2015-2020)
3.5 Manufacturers Iron Chelation Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Iron Chelation Drug Players (Opinion Leaders)
4 Global Iron Chelation Drug Market Size by Type
4.1 Global Iron Chelation Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Iron Chelation Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Iron Chelation Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Iron Chelation Drug Price by Type (2014-2020)
4.2 Global Iron Chelation Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Iron Chelation Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Iron Chelation Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Iron Chelation Drug Price Forecast by Type (2021-2026)
5 Global Iron Chelation Drug Market Size by Application
5.1 Global Iron Chelation Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Iron Chelation Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Iron Chelation Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Iron Chelation Drug Price by Application (2015-2020)
5.2 Global Iron Chelation Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Iron Chelation Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Iron Chelation Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Iron Chelation Drug Price Forecast by Application (2021-2026)

3 North America Iron Chelation Drug Market Facts & Figures
3.2 North America Iron Chelation Drug Sales Market Share by Company (2015-2020)
3.3 North America Iron Chelation Drug Sales Market Share by Type (2015-2020)
3.4 North America Iron Chelation Drug Sales Market Share by Application (2015-2020)

4 Europe Iron Chelation Drug Market Facts & Figures
4.2 Europe Iron Chelation Drug Sales Market Share by Company (2015-2020)
4.3 Europe Iron Chelation Drug Sales Market Share by Type (2015-2020)
4.4 Europe Iron Chelation Drug Sales Market Share by Application (2015-2020)

5 China Iron Chelation Drug Market Facts & Figures
5.2 China Iron Chelation Drug Sales Market Share by Company (2015-2020)
5.3 China Iron Chelation Drug Sales Market Share by Type (2015-2020)
5.4 China Iron Chelation Drug Sales Market Share by Application (2015-2020)

6 Japan Iron Chelation Drug Market Facts & Figures
6.2 Japan Iron Chelation Drug Sales Market Share by Company (2015-2020)
6.3 Japan Iron Chelation Drug Sales Market Share by Type (2015-2020)
6.4 Japan Iron Chelation Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Iron Chelation Drug Market Facts & Figures
7.2 Southeast Asia Iron Chelation Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Iron Chelation Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Iron Chelation Drug Sales Market Share by Application (2015-2020)

8 India Iron Chelation Drug Market Facts & Figures
8.2 India Iron Chelation Drug Sales Market Share by Company (2015-2020)
8.3 India Iron Chelation Drug Sales Market Share by Type (2015-2020)
8.4 India Iron Chelation Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Iron Chelation Drug Business
12.1 Apotex Inc. (Canada)
12.1.1 Apotex Inc. (Canada) Iron Chelation Drug Corporation Information
12.1.2 Apotex Inc. (Canada) Iron Chelation Drug Business Overview and Total Revenue
12.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Apotex Inc. (Canada) Iron Chelation Drug Products Offered
12.1.5 Apotex Inc. (Canada) Recent Development
12.2 Cipla (India)
12.2.1 Cipla (India) Iron Chelation Drug Corporation Information
12.2.2 Cipla (India) Iron Chelation Drug Business Overview and Total Revenue
12.2.3 Cipla (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cipla (India) Iron Chelation Drug Products Offered
12.2.5 Cipla (India) Recent Development
12.3 Novartis (Switzerland)
12.3.1 Novartis (Switzerland) Iron Chelation Drug Corporation Information
12.3.2 Novartis (Switzerland) Iron Chelation Drug Business Overview and Total Revenue
12.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis (Switzerland) Iron Chelation Drug Products Offered
12.3.5 Novartis (Switzerland) Recent Development
12.4 Sun Pharma (India)
12.4.1 Sun Pharma (India) Iron Chelation Drug Corporation Information
12.4.2 Sun Pharma (India) Iron Chelation Drug Business Overview and Total Revenue
12.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharma (India) Iron Chelation Drug Products Offered
12.4.5 Sun Pharma (India) Recent Development
12.5 Natco Pharma (India)
12.5.1 Natco Pharma (India) Iron Chelation Drug Corporation Information
12.5.2 Natco Pharma (India) Iron Chelation Drug Business Overview and Total Revenue
12.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Natco Pharma (India) Iron Chelation Drug Products Offered
12.5.5 Natco Pharma (India) Recent Development

13 Iron Chelation Drug Manufacturing Cost Analysis
13.1 Iron Chelation Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Iron Chelation Drug
13.4 Iron Chelation Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Iron Chelation Drug Distributors List
14.3 Iron Chelation Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Iron Chelation Drug Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Iron Chelation Drug Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Iron Chelation Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Iron Chelation Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Iron Chelation Drug Players to Combat Covid-19 Impact
Table 8. Global Market Iron Chelation Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Iron Chelation Drug Sales (Kg) by Region (2015-2020)
Table 10. Global Iron Chelation Drug Sales Market Share by Region (2015-2020)
Table 11. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Iron Chelation Drug Revenue Share by Region (2015-2020)
Table 13. Global Iron Chelation Drug Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Iron Chelation Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Iron Chelation Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Iron Chelation Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Iron Chelation Drug (Kg) of Key Companies (2015-2020)
Table 18. Global Iron Chelation Drug Sales Share by Company (2015-2020)
Table 19. Global Iron Chelation Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Iron Chelation Drug Revenue Share by Company (2015-2020)
Table 21. Global Iron Chelation Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Chelation Drug as of 2019)
Table 22. Global Iron Chelation Drug Average Price (USD/g) of Key Company (2015-2020)
Table 23. Manufacturers Iron Chelation Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Iron Chelation Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Iron Chelation Drug Players
Table 27. Global Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 28. Global Iron Chelation Drug Sales Share by Type (2015-2020)
Table 29. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Iron Chelation Drug Price (Kg) by Type (2015-2020)
Table 31. Global Iron Chelation Drug Sales Share by Type (2021-2026)
Table 32. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Iron Chelation Drug Revenue Share by Type (2021-2026)
Table 34. Global Iron Chelation Drug Price (Kg) by Type (2021-2026)
Table 35. Global Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 36. Global Iron Chelation Drug Sales Share by Application (2015-2020)
Table 37. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Iron Chelation Drug Price (Kg) by Application (2015-2020)
Table 39. Global Iron Chelation Drug Sales (Kg) by Application (2021-2026)
Table 40. Global Iron Chelation Drug Sales Share by Application (2021-2026)
Table 41. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Iron Chelation Drug Revenue Share by Application (2021-2026)
Table 43. Global Iron Chelation Drug Price (Kg) by Application (2021-2026)
Table 44. United States Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 45. United States Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 46. United States Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 47. United States Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 48. United States Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 49. United States Iron Chelation Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 51. Europe Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 53. Europe Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 55. Europe Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 56. China Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 57. China Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 58. China Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 59. China Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 60. China Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 61. China Iron Chelation Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 63. Japan Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 65. Japan Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 67. Japan Iron Chelation Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Iron Chelation Drug Sales Market Share by Application (2015-2020)
Table 74. India Iron Chelation Drug Sales (Kg) by Company (2015-2020)
Table 75. India Iron Chelation Drug Sales Market Share by Company (2015-2020)
Table 76. India Iron Chelation Drug Sales (Kg) by Type (2015-2020)
Table 77. India Iron Chelation Drug Sales Market Share by Type (2015-2020)
Table 78. India Iron Chelation Drug Sales (Kg) by Application (2015-2020)
Table 79. India Iron Chelation Drug Sales Market Share by Application (2015-2020)
Table 80. Apotex Inc. (Canada) Corporation Information
Table 81. Apotex Inc. (Canada) Description and Business Overview
Table 82. Apotex Inc. (Canada) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Apotex Inc. (Canada) Iron Chelation Drug Product
Table 84. Apotex Inc. (Canada) Recent Development
Table 85. Cipla (India) Corporation Information
Table 86. Cipla (India) Description and Business Overview
Table 87. Cipla (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 88. Cipla (India) Iron Chelation Drug Product
Table 89. Cipla (India) Recent Development
Table 90. Novartis (Switzerland) Corporation Information
Table 91. Novartis (Switzerland) Description and Business Overview
Table 92. Novartis (Switzerland) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 93. Novartis (Switzerland) Iron Chelation Drug Product
Table 94. Novartis (Switzerland) Recent Development
Table 95. Sun Pharma (India) Corporation Information
Table 96. Sun Pharma (India) Description and Business Overview
Table 97. Sun Pharma (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 98. Sun Pharma (India) Iron Chelation Drug Product
Table 99. Sun Pharma (India) Recent Development
Table . Natco Pharma (India) Corporation Information
Table . Natco Pharma (India) Description and Business Overview
Table . Natco Pharma (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table . Natco Pharma (India) Iron Chelation Drug Product
Table . Natco Pharma (India) Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Iron Chelation Drug Distributors List
Table 108. Iron Chelation Drug Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Iron Chelation Drug Product Picture
Figure 2. Global Iron Chelation Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Iron Chelation Drug Market Share by Application in 2020 & 2026
Figure 6. Transfusional Iron Overload Examples
Figure 7. NTDT Caused Iron Overload Examples
Figure 8. Global Iron Chelation Drug Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Iron Chelation Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Iron Chelation Drug Price Trends Growth Rate (2015-2026) (USD/g)
Figure 11. Global Iron Chelation Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Iron Chelation Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Iron Chelation Drug Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Iron Chelation Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Iron Chelation Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Iron Chelation Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Iron Chelation Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Iron Chelation Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Iron Chelation Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Iron Chelation Drug Players Market Share by Revenue in Iron Chelation Drug 2015 & 2019
Figure 26. Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Iron Chelation Drug Revenue Share by Type (2015-2020)
Figure 28. Global Iron Chelation Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Iron Chelation Drug Revenue Share by Application (2015-2020)
Figure 30. Global Iron Chelation Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Iron Chelation Drug Sales Market Share by Type in 2019
Figure 32. United States Iron Chelation Drug Sales Market Share by Type in 2019
Figure 33. Europe Iron Chelation Drug Sales Market Share by Company in 2019
Figure 34. Europe Iron Chelation Drug Sales Market Share by Type in 2019
Figure 35. Europe Iron Chelation Drug Sales Market Share by Application in 2019
Figure 36. China Iron Chelation Drug Sales Market Share by Company in 2019
Figure 37. China Iron Chelation Drug Sales Market Share by Type in 2019
Figure 38. China Iron Chelation Drug Sales Market Share by Application in 2019
Figure 39. Japan Iron Chelation Drug Sales Market Share by Company in 2019
Figure 40. Japan Iron Chelation Drug Sales Market Share by Type in 2019
Figure 41. Japan Iron Chelation Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Iron Chelation Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Iron Chelation Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Iron Chelation Drug Sales Market Share by Application in 2019
Figure 45. India Iron Chelation Drug Sales Market Share by Company in 2019
Figure 46. India Iron Chelation Drug Sales Market Share by Type in 2019
Figure 47. India Iron Chelation Drug Sales Market Share by Application in 2019
Figure 48. Apotex Inc. (Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cipla (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis (Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sun Pharma (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Natco Pharma (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Iron Chelation Drug
Figure 55. Manufacturing Process Analysis of Iron Chelation Drug
Figure 56. Iron Chelation Drug Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed